Keyphrases
Oral Tongue Squamous Cell Carcinoma (OTSCC)
100%
Head-and-neck Cancer
29%
Head-and-neck Radiotherapy
27%
Oral Cancer
24%
Tumor
23%
Radiotherapy
23%
Metastasis
21%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
20%
Chile
19%
C-X-C Chemokine Receptor Type 4 (CXCR4)
19%
Scoping Review
18%
Immunoexpression
18%
Temporomandibular Disorders
17%
Oral Leukoplakia
17%
Malignant Transformation
17%
C-C Chemokine Receptor Type 5 (CCR5)
16%
Lymph Node Metastasis
14%
Immunohistochemistry
13%
Poor Survival
13%
Cancer Patients
12%
Overexpression
12%
Mucoepidermoid Carcinoma
12%
Oral Pathology
12%
Oral Medicine
12%
Microenvironment
12%
Saliva
12%
CCR7
11%
Human Epidermal Growth Factor Receptor 2 (HER2)
11%
Mandibular Kinematics
11%
CCR4
11%
South America
11%
Clinicopathological Significance
11%
SPLUNC1
11%
Auxiliary Tool
11%
Salivary Gland
11%
Cancer Genetic Counseling
11%
Seizing Opportunities
11%
Challenges Opportunities
11%
Genetic Counseling
11%
Social Determinants of Oral Health
11%
Indigenous Communities
11%
Histological Architecture
11%
Buccal mucosa
11%
Histopathological Features
10%
Oral Potentially Malignant Disorders
9%
SPLUNC2
9%
Mast Cells
9%
Fucose
9%
Chemokine Ligand 12 (CXCL12)
8%
CCL5
8%
Medicine and Dentistry
Mouth Squamous Cell Carcinoma
74%
Neoplasm
37%
Disease
23%
Neck Radiotherapy
22%
Head Radiotherapy
22%
Metastatic Carcinoma
21%
Head and Neck Squamous Cell Carcinoma
19%
Systematic Review
18%
Malignant Neoplasm
18%
Oral Cancer
18%
Head and Neck Cancer
18%
Malignant Transformation
18%
Radiation Therapy
18%
Leukoplakia
17%
Recurrent Disease
15%
Lymph Node Metastasis
14%
Tongue
13%
Mouth
13%
Chemokine Receptor CXCR4
12%
Mucoepidermoid Carcinoma
12%
Oral Medicine
12%
Dentin
11%
Protein P53
11%
Salivary Gland
11%
Oral Mucosa
11%
Genetic Counseling
11%
Cancer Genetics
11%
Diagnosis
11%
Side Effect
10%
Carcinoma
9%
Adhesive Agent
9%
Mast Cell
9%
Buccal Mucosa
9%
Mucosa
9%
Dysplasia
8%
microRNA
8%
Pigmentation
8%
Chemokine
8%
Dentist
8%
Immunohistochemistry
8%
Chi Square Test
7%
Clinical Stage
7%
Clinical Feature
7%
Cancer Therapy
7%
Disease Free Survival
7%
Ectasia
7%
Chemokine Receptor CCR5 Antagonist
7%
Salivary Gland Neoplasm
7%
Adverse Event
7%
Perineural Invasion
7%